Fredun Pharmaceuticals Gains 12.79%: 5 Key Factors Driving the Surge
2026-11-21 14:00:06Key Events This Week 16 Nov: Stock opens at Rs.1,487.35, down 0.93% amid flat Sensex 17 Nov: Sharp rebound with 5.80% gain to Rs.1,573.55 19 Nov: New 52-week and all-time high at Rs.1,680.65 20 Nov: Hits fresh 52-week and all-time high at Rs.1,730.80 before closing at Rs.1,693.30 Week Open Rs.1,501.25 ...
Read More
Fredun Pharmaceuticals Ltd Hits All-Time High of Rs 1,730.8 as Momentum Builds Across Timeframes
2026-11-20 09:34:14Extending its winning streak to four consecutive sessions, Fredun Pharmaceuticals Ltd touched a fresh all-time high of Rs 1,730.8 on 20 Nov 2026, marking a remarkable rally of over 15% in just four days. This surge comes amid sustained outperformance against the broader Sensex and its sector peers, reflecting strong investor enthusiasm despite a minor dip of 0.28% on the day.
Read More
Fredun Pharmaceuticals Ltd Sees Bullish Momentum Amid Technical Indicator Shifts
2026-11-20 08:04:14Fredun Pharmaceuticals Ltd has demonstrated a notable shift in price momentum, supported by a series of technical indicator upgrades that signal renewed bullish sentiment. The micro-cap pharmaceutical company’s shares surged 4.49% today, closing at ₹1,707.70, just shy of its 52-week high of ₹1,712.00, reflecting strong investor interest amid evolving market dynamics.
Read More
Fredun Pharmaceuticals Ltd: Valuation Shift Signals Price Attractiveness Change
2026-11-13 08:01:25Fredun Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from fair to expensive territory. This change, reflected in key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, invites a closer examination of the stock’s price attractiveness relative to its historical averages and peer group.
Read More
Fredun Pharmaceuticals Ltd is Rated Buy
2026-11-11 10:10:52Fredun Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 08 October 2026. However, the analysis and financial metrics discussed below reflect the company’s current position as of 11 November 2026, providing investors with the latest insights into its performance and outlook.
Read MoreFredun Pharmaceuticals Gains 7.88%: 2 Key Factors Driving the Weekly Rally
2026-11-07 14:00:41Key Events This Week Nov 2: Technical momentum shift noted amid mixed indicator signals Nov 3: Continued price gains supported by positive market sentiment Nov 4: Stock hits weekly high of Rs.1,509.60 (+3.76%) Nov 5: Q2 FY27 results announced with 97% profit surge Nov 6: Week closes at Rs.1,473.70 (-1.32%) after profit-taking Week Open ...
Read More
Fredun Pharmaceuticals Ltd is Rated Buy
2026-10-31 10:10:24Fredun Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 08 Oct 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 October 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.
Read More
Fredun Pharmaceuticals Ltd Technical Momentum Shifts Signal Bullish Outlook
2026-10-27 08:05:46Fredun Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. This transition is underscored by mixed but increasingly positive signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, suggesting a strengthening price momentum despite recent minor price fluctuations.
Read MoreAnnouncement under Regulation 30 (LODR)-Earnings Call Transcript
19-Nov-2026 | Source : BSETranscript of the Earnings conference call held on 16th November 2026 for Q2 H1 FY 2027.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
16-Nov-2026 | Source : BSEAudio Recording Q2 & H1 FY27 Earnings Conference Call of Fredun Pharmaceuticals Limited.
Board Meeting Outcome for Board Meeting Outcome For Outcome Of Board Meeting Dated 14.11.2026
14-Nov-2026 | Source : BSEOutcome of the Board Meeting of Fredun Pharmaceuticals Limited (Company) pursuant to Regulation 30 of Schedule III of the SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015.
Corporate Actions
No Upcoming Board Meetings
Fredun Pharmaceuticals Ltd has declared 7% dividend, ex-date: 23 Jun 26
No Splits history available
Fredun Pharmaceuticals Ltd has announced 2:1 bonus issue, ex-date: 16 Jul 26
No Rights history available
